RBC Capital sets USD 130 target for Abbott Laboratories stock
Published on 10/08/2026 at 16:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Abbott Laboratories stock (ISIN US0028241000) was trading at EUR 87.74 at Lang & Schwarz on October 8, 2026, up 0.06 percent versus the prior close of EUR 87.69. Markets Insider reported that RBC Capital maintained its Buy rating and set a USD 130.00 price target on October 1, 2026.
RBC target sets the benchmark
The target gives the analyst view a clear numerical anchor, but it is denominated in USD rather than the Lang & Schwarz reference price in EUR. At 10:12 a.m. ET on October 8, 2026, Abbott's NYSE quote was USD 97.58, while its 52-week range was USD 81.97 to USD 135.13.
MarketBeat reported that Abbott delivered adjusted earnings per share of USD 1.31 versus USD 1.28 expected in the second quarter, while revenue reached USD 12.59 billion, up 13.00 percent year over year.
What does the target imply?
RBC's USD 130.00 target sits above the USD 97.58 NYSE quote cited for October 8, 2026, but the two values belong to different dates and the reference currencies differ. The operating comparison is more immediate: second-quarter revenue increased from USD 11.14 billion a year earlier, while net profit fell to USD 928.00 million from USD 1.78 billion, according to Markets Insider.
Three dated Abbott signals
On July 16, 2026, MarketBeat said adjusted earnings per share reached USD 1.31 against USD 1.28 expected. On September 17, 2026, Yahoo Finance reported a quarterly dividend of USD 0.63 per share. On October 1, 2026, RBC Capital set the USD 130.00 target while maintaining its Buy rating, as reported by Markets Insider.
Dates for dividends and results
Yahoo Finance listed October 15, 2026 as the ex-dividend date and October 21, 2026 as the date for fiscal third-quarter results. Analysts forecast adjusted earnings per share of USD 1.43 for that quarter, versus USD 1.30 a year earlier.
Price holds near the lower range
Abbott's market capitalization was USD 168.9 billion on October 8, 2026, and the EUR 87.74 Lang & Schwarz price stood within the current trading context defined by the US quote range. The further course of trading is shown by the continuously updated real-time quote of Abbott Laboratories stock.
Abbott Laboratories stock facts
- Company: Abbott Laboratories
- ISIN: US0028241000
- Ticker: ABT
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 8, 2026, 4:05 p.m. CEST: EUR 87.74
- Change versus prior close: plus 0.06 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 87.69
- Market capitalization: USD 168.9 billion (as of October 8, 2026)
- 52-week range: USD 81.97-135.13 (as of October 8, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: October 21, 2026
Market context: Market report S&P 500.
